PUBLICATIONS & PRESENTATIONS

EA and Hoskins WJ. The role of second-look surgery in the management of epithelial ovarian cancer. Contemp Oncol 1995. Special Report on Ovarian Cancer: State of the art diagnosis and management. Ed. J.R. Lurain.

Poynor EA. Managing cervical adenocarcinoma in situ. OBG Management. August 1998: 47-57.

Poynor EA. Cancer Screening for Women. Oncology Special Edition 1999;2: 108-110.

Poynor EA, Hoskins WJ. Cancer of the Ovary. Bland KI, Daly JM, Karakousis CP (Eds.). Surgical Oncology: Contemporary Principles and Practice. McGraw Hill, 2001:911-950.

Poynor EA and Offit K. Ovarian cancer with a family History. Lederman JA, Hoskins WJ, Kaye SB, Vegote I (Eds.) Clinical management of Ovarian Cancer. London: Martin Dunetz, 2001:215-228.

Poynor EA, Barakat RR, Hoskins WJ. The management and follow-up of adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995; 57:158-164.

Boyd J, Sonoda Y, Federici MG, Bogomoliny F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ. Clinicopathologic features of BRCA1-linked and sporadic ovarian cancer. JAMA. 2000; 283(17):2260-5.

Husain A, Curitn J, Corrigan K, Brown C, Poynor E, Chi D, Barakat RR. Continent urinary diversion in patients undergoing exenterative or palliative procedures for recurrent gynecologic cancers. Gynecol Oncol 2000; 78(2):208-11.

Sills ES, Poynor EA, Moomjy M. Ovarian hyperstimulation following accidental daily clomiphene citrate use over three consecutive months. Reprod Toxicol 2000;14:541-543.

Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. The role of laparoscopy in second look evaluations for ovarian cancer. Gynecol Oncol 2001 Jan;80(1):44-7.

Dizon DS, Hensley M, Poynor EA, Sabbatini P, Aghajanian C, Hummer A, Venkatraman E , and Spriggs DR. Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma. J Clin Oncol 2002 Mar 1;20(5):1238-47.

Mark Robson, Martee Hensley; Richard Barakat; Carol Brown; Dennis Chi; Elizabeth Poynor; Kenneth Offit. Quality of Life in Women at Risk for Ovarian Cancer who have Undergone Risk-Reducing Oophorectomy. Gynecol Oncol. 2003 May;89(2):281-7.

Abu-Rustum NR, Chi DS, Sonoda Y, DiClemente MJ, Bekker G, Gemignani M, Poynor E, Brown C, Barakat RR. Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: an 8-year study and description of technique. Gynecol Oncol. 2003 Jun;89(3):504-13.

Levine DA, Villella JA, Poynor EA, Soslow RA. Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary. Gynecol Oncol. 2004 Aug;94(2):597-9.

Miner TJ, Delgado R, Zeisler J, Busam K, Alektiar K, Barakat R, Poynor E. Primary vaginal melanoma: a critical analysis of therapy. Ann Surg Oncol. 2004 Jan;11(1):34-9.

Abu-Rustum NR, Gemignani ML, Moore K, Sonoda Y, Venkatraman E, Brown C, Poynor E, Chi DS, Barakat RR. Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy. Gynecol Oncol. 2003 Nov;91(2):402-9. Erratum in: Gynecol Oncol. 2004 Apr;93(1):275.

Sonoda Y, Abu-Rustum NR, Gemignani ML, Chi DS, Brown CL, Poynor EA, Barakat RR.A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol. 2004 Dec;95(3):534-8.

Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol. 2004 Sep;94(3):650-4.

Bochner BH, McCreath WA, Aubey JJ, Levine DA, Barakat RR, Abu-Rustum N, Poynor E, Wong D, Chi DS. Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecol Oncol. 2004 Jul;94(1):140-6.

Sonoda Y, Abu-Rustum NR, Gemignani ML, Chi DS, Brown CL, Poynor EA, Barakat RR. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol. 2004 Dec;95(3):534-8.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Fifth International Conference on Ovarian Cancer: challenges and opportunities. Gynecol Oncol. 2005 Jun;97(3):916-23.

Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow RA. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.Gynecol Oncol. 2006 Dec;103(3):960-5.

Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR, Chi DS. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.Gynecol Oncol. 2006 Dec;103(3):1083-90.

Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clin Cancer Res. 2006 Sep 15;12(18):5503-10.

Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Gynecol Oncol. 2007 Jan;104(1):176-80.

Poynor EA, Barakat RR, Curtin JP, Hoskins WJ. The role of bowel surgery in the management of epithelial ovarian cancer. Presented at the 1995 meeting of the Society of Surgical Oncology.

Poynor E, Barakat R, Brown K, Offitt K, Corrigan K, Hoskins WJ. Clinicopathologic features of familial and hereditary ovarian cancers. Gynecol Oncol 1996; 60:114.

Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ. Clinical and Pathologic Features of Hereditary Ovarian Cancers Associated with Germline Mutations in BRCA1 or BRCA2. Abstract # 6. The 30th Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 1999;72:444.

Aghajanian C, Sabbatini P, Hensley M, Tong W, Soignet S, Hoskins W, Brown C, Poynor E, O'Connor K, Pezzulli S, Barakat R, Spriggs D. A Phase I Trial of Intraperitoneal (IP) Cisplatin with IP Gemcitabine in Patients (Pts) with Epithelial Ovarian Cancer. Abstract # 1428. ASCO 35th Annual Meeting, 1999.

Husain A, Chi DS, Prasad M, Abu-Rustum NR, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. The Role of Laparoscopy in Second-Look Evaluations for Ovarian Cancer. Poster presentation. SGO 31st Annual Meeting, 2000.

Sonoda Y, Zerbe M, Barakat RR, Brown CL, Chi DS, Poynor EA, Hoskins WJ. High Incidence of Positive Peritoneal Cytology in Low-Risk Endometrial Cancer Treated by Laparoscopically Assisted Vaginal Hysterectomy (LAVH). Abstract #19. 31st Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 2000;76(2):235.

Husain A, Chi DS, Prasad Manju, Abu-rustum NR, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. The Role of Laparoscopy in Second-look Evaluations for Ovarian Cancer. Abstract #85. 31st Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 2000;76(2):253.

Sonoda Y, Husain A, Sabbatini P, Chi DS, Poynor EA, Brown CL, Hoskins WJ, Barakat RR. A Comparison of Paclitaxel-Based Chemotherapy in Papillary Serous Carcinoma of the Peritoneum (PSCP) and Papillary Serous Carcinoma of the Ovary (PSCO). Poster presentation. Abstract #87. 31st Annual Meeting of the Society of Gynecologic Oncologist, Feb. 5-9, 2000. Gynecol Oncol 2000;76(2):253.

Poynor EA, Luzzatto LL, Federici MG, Boyd JA, Hoskins WJ. Use of Microarray Technology in the Investigation of the Genes Important in the Pathogenesis of Epithelial Ovarian Cancer (EOC). Poster presentation. Abstract #91. 31st Annual Meeting of the Society of Gynecologic Oncologist, Feb. 5-9, 2000.

Sonoda Y, Zerbe M, Barakat RR, Brown CL, Chi DS, Poynor EA, Hoskins WJ.High Incidence of Positive Peritoneal Cytology in Low-Risk Endometrial Cancer Treated by Laparoscopically Assisted Vaginal Hysterectomy (LAVH). Abstract. The 2000 SmithKline Beecham National Gynecologic Oncology Fellows' Forum. February 24-27, 2000, San Diego, California.

Dennis S. Chi, Corinna C. Franklin, Douglas A. Levine, Faina Akselrod, Paul Sabbatini, William R. Jarnagin, Ronald Dematteo, Elizabeth A. Poynor, Nadeem Abu-Rustum, Richard R. Barakat. Improved Optimal Cytoreduction Rates for Stage IIIC and IV Epithelial Ovarian Cancer: Change in Surgical Approach. Abstract #44. 34st Annual Meeting of the Society of Gynecologic Oncologist, January 31 - February 4, 2003.

Nadeem Abu-Rustum, Dennis S. Chi, Yukio Sonoda, M. J. Diclemente, G. Bekker, Carol L. Brown, Elizabeth A. Poynor, Mary L. Gemignani, Richard R. Barakat. Memorial Sloan-Kettering Cancer Ctr, New York, NY.Low Complication Rate of Laparoscopic Pelvic and Aortic Lymph Node Dissection Using the Argon-Beam Coagulator or Monopolar Instruments: An 8-Year StudyAbstract #: 97 :34th Annual Meeting January 31 - February 4, 2003.

Nadeem Abu-Rustum, Dennis S. Chi, Yukio Sonoda, Carol L. Brown, Mary L. Gemignani, Elizabeth A. Poynor, Richard R. Barakat. Memorial Sloan-Kettering Cancer Ctr, New York, NY.Trocar-Related Tumor Implantation: A Review of 1080 Transperitoneal Laparoscopies in Women with Malignant Disease. Abstract #: 97:34th Annual Meeting January 31 - February 4, 2003.

Elizabeth A. Poynor, Valbona Behaj, Andrew J. Meltzer, Andrew C. Koff, Richard R. Barakat, Jeff A. Boyd. Memorial Sloan-Kettering Cancer Ctr, New York, NY.ZIC2 Gene Expression in Epithelial Ovarian CancerAbstract #: 200 34th Annual Meeting January 31 - February 4, 2003 .

“Emerging Treatments for Gynecologic Cancers” Invited speaker Gilda’s Club of Westchester, New York 2004

“Hormone Replacement Therapy and the Women’s Health Initiative”

“Genetics and Cancer Risk Management” Invited speaker, Grand Rounds Day Henry Ford Hospital Detroit, Michigan 2004

“Prophylactic Surgery for the Prevention of Ovarian Cancer” and Moderator International Conference on Ovarian Cancer MD Anderson Cancer Center Houston, Texas 2004

“ZIC2 and Epithelial Ovarian Cancer” Surgical Grand Rounds Memorial Sloan Kettering Cancer Center 2004

“Microarray Analysis of Epithelial Ovarian Cancer” Surgical Research Conference Memorial Sloan Kettering Cancer Center 2004

“Tumor Endothelium as a Target for Ionizing Radiation” Surgical Chairman’s Conference Memorial Sloan Kettering Cancer Center 2004

“Update on the Society of Gynecologic Oncologists Meeting” Invited speaker SHARE New York, New York 2005

“Molecular Oncology and Targeted Treatments” Invited Speaker Florida Obstetric and Gynecologic Society Jacksonville, Florida 2005

“Exploring the Connection between Breast and Ovarian Cancer” Invited Speaker Sharsharet Teakneck, NJ 2006

“Genetic Basis for Ovarian Cancer” Invited Speaker Central Synagogue New York, NY 2007

Teleconference concerning women’s sexual health after breast cancer for Shasharet, Teaneck, NJ 2007

ShareCare.com, Dr. Poynor can be found as an Expertin Obstetrics and Gynecology

Dr. Poynor's expertiseon Obstetrics and Gynecology is part of Expert on CancerOpinions.com.

Dr. Poynor is a contributor to Fran Drescher's site  where they are fighting cancer a different way: CATCHING IT EARLY

Dr. Dr. Poynor is a contributor to Womens Voices for Change

Dr. Poynor has contributed 28 about surgery, Obstetrics and Gynecology and cancer articles to the Da Vinci Surgery website

Dr. Poynor is a friend of Healthy Choice Compounding Pharmacy in Chappaqua NY